144655-81-2 Usage
Uses
Used in Pharmaceutical Industry:
4-(2-Oxoimidazolidin-1-yl)benzonitrile is used as a key intermediate in the synthesis of various pharmaceutical products, specifically for the development of anti-cancer and antiviral drugs. Its chemical structure allows it to be a versatile building block in the creation of new medicinal compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(2-Oxoimidazolidin-1-yl)benzonitrile is utilized as a reagent, contributing to the formation of complex organic molecules. Its unique properties make it suitable for a range of chemical reactions, facilitating the synthesis of diverse organic compounds.
Used in Laboratory Research:
4-(2-Oxoimidazolidin-1-yl)benzonitrile also serves as a valuable reagent in laboratory research, where it is employed to study chemical reactions and explore new synthetic pathways. Its application in research helps scientists to better understand chemical processes and develop innovative solutions in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 144655-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,6,5 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 144655-81:
(8*1)+(7*4)+(6*4)+(5*6)+(4*5)+(3*5)+(2*8)+(1*1)=142
142 % 10 = 2
So 144655-81-2 is a valid CAS Registry Number.
144655-81-2Relevant academic research and scientific papers
IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS
-
Page/Page column 81-82, (2019/10/15)
The present invention relates to the derivatives of compound of formula (I) and pharmaceutically acceptable salts thereof. The present invention further provides the methods of preparation of compound of formula (I) and use thereof as PRMT5 inhibitors. Th
Mild, convenient and versatile Cu-mediated synthesis of N-aryl-2-imidazolidinones
Stabile, Paolo,Lamonica, Alessandro,Ribecai, Arianna,Castoldi, Damiano,Guercio, Giuseppe,Curcuruto, Ornella
supporting information; experimental part, p. 3232 - 3235 (2010/08/07)
A mild, general, convenient and practical methodology for the selective copper-mediated mono N-arylation of unprotected 2-imidazolidinone was developed. Strong electron-donating groups and free hydroxy and amino groups on the aryl iodide substrates were well tolerated. The use of n-butanol as the solvent for the copper-catalysed mono-arylation of 2-imidazolidinone is unprecedented.
Platelet aggregation inhibitors
-
, (2008/06/13)
This invention relates to compounds having the following formula STR1 or a pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.
